PFKFB3 and lung carcinoma: In our previous work, we demonstrated for the first time that KAN0438757, a selective PFKFB3 inhibitor, exhibits potent anticancer activity by markedly reducing the survival and proliferation of A549 and H1299 lung cancer cells and suppressing colony formation and migration in A549 cells.